Evidence map›Paper›PMID 30911438›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2019

PET/DW-MRI for evaluating treatment in chronic hepatitis C patients.

Rikke J Petersen, Nick S Nielsen, Helle H Johannesen, Adam E Hansen, Sofie Jespersen, Caroline J Arnbjerg, Johan Löfgren, Mette S Kjær, Mette R Clausen, Andreas Kjær and 2 more

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Rikke J PetersenDepartment of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen Denmark.
Nick S NielsenDepartment of Infectious Diseases, Rigshospitalet, University of Copenhagen Denmark.
Helle H JohannesenDepartment of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen Denmark.
Adam E HansenDepartment of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen Denmark.
Sofie JespersenDepartment of Infectious Diseases, Rigshospitalet, University of Copenhagen Denmark.
Caroline J ArnbjergDepartment of Infectious Diseases, Rigshospitalet, University of Copenhagen Denmark.
Johan LöfgrenDepartment of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen Denmark.
Mette S KjærDepartment of Hepatology, Rigshospitalet, University of Copenhagen Denmark.
Mette R ClausenDepartment of Hepatology, Rigshospitalet, University of Copenhagen Denmark.
Andreas KjærDepartment of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen Denmark.
Susanne D NielsenDepartment of Infectious Diseases, Rigshospitalet, University of Copenhagen Denmark.
Barbara M FischerDepartment of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen Denmark.
Rigshospitalet · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This feasibility study set out to investigate the use of FDG-PET/DW-MRI in chronic hepatitis C patients to examine changes in local liver inflammation after treatment with direct-acting antivirals (DAA). Twelve patients with chronic hepatitis C were prospectively enrolled, performing FDG-PET/DW-MRI prior to and after DAA treatment. PET/DW-MRI included PET acquisition 60 and 90 min after FDG-injection, DIXON, for attenuation correction, T2- and DW-MRI with 10 b-values between 0-700 s/mm

Indexed as

chronic hepatitis Cdiffusion weighted MRIFDG-PETinflammationPET/MRIresponse evaluation

Identifiers

PMID30911438
PMCPMC6420713
OpenAlexW2921456493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.